Crossmark

PCA3 as a second-line biomarker in a prospective controlled randomized opportunistic prostate cancer screening programme

Crossref DOI link: https://doi.org/10.1016/j.acuroe.2017.04.003

Published Print: 2017-06

Update policy: https://doi.org/10.1016/elsevier_cm_policy

Authors

Rubio-Briones, J.

Casanova, J.

Martínez, F.

Domínguez-Escrig, J.L.

Fernández-Serra, A.

Dumont, R.

Ramírez-Backhaus, M.

Gómez-Ferrer, A.

Collado, A.

Rubio, L.

Molina, A.

Vanaclocha, M.

Sala, D.

Lopez-Guerrero, J.A.
License Information

Text and Data Mining valid from 2017-06-01
More Information

This article is maintained by: Elsevier

Article Title: PCA3 as a second-line biomarker in a prospective controlled randomized opportunistic prostate cancer screening programme

Journal Title: Actas Urológicas Españolas (English Edition)

CrossRef DOI link to publisher maintained version: https://doi.org/10.1016/j.acuroe.2017.04.003

CrossRef DOI link to the associated document: https://doi.org/10.1016/j.acuro.2016.10.008

Content Type: article

Copyright: © 2016 AEU. Published by Elsevier España, S.L.U. All rights reserved.